ATC code A02

ATC codes

A Alimentary tract and metabolism

A01 Stomatological preparations

A02 Drugs for acid related disorders

A03 Drugs for functional gastrointestinal disorders

A04 Antiemetics and antinauseants

A05 Bile and liver therapy

A06 Drugs for constipation

A07 Antidiarrheals, intestinal anti-inflammatory/anti-infective agents

A08 Antiobesity preparations, excluding diet products

A09 Digestives, including enzymes

A10 Drugs used in diabetes

A11 Vitamins

A12 Mineral supplements

A13 Tonics

A14 Anabolic agents for systemic use

A15 Appetite stimulants

A16 Other alimentary tract and metabolism products

ATC code A02 Drugs for acid related disorders is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup A02 is part of the anatomical group A Alimentary tract and metabolism.^[1]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QA02...^[2]

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.

A02A Antacids

A02AA Magnesium compounds

A02AA01 Magnesium carbonate

A02AA02 Magnesium oxide

A02AA03 Magnesium peroxide

A02AA04 Magnesium hydroxide

A02AA05 Magnesium silicate

A02AA10 Combinations

A02AB Aluminium compounds

A02AB01 Aluminium hydroxide

A02AB02 Algeldrate

A02AB03 Aluminium phosphate

A02AB04 Dihydroxialumini sodium carbonate

A02AB05 Aluminium acetoacetate

A02AB06 Aloglutamol

A02AB07 Aluminium glycinate

A02AB10 Combinations

A02AC Calcium compounds

A02AC01 Calcium carbonate

A02AC02 Calcium silicate

A02AC10 Combinations

A02AD Combinations and complexes of aluminium, calcium and magnesium compounds

A02AD01 Ordinary salt combinations

A02AD02 Magaldrate

A02AD03 Almagate

A02AD04 Hydrotalcite

A02AD05 Almasilate

A02AF Antacids with antiflatulents

A02AF01 Magaldrate and antiflatulents

A02AF02 Ordinary salt combinations and antiflatulents

A02B Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)

A02BA H2-receptor antagonists

A02BA01 Cimetidine

A02BA02 Ranitidine

A02BA03 Famotidine

A02BA04 Nizatidine

A02BA05 Niperotidine

A02BA06 Roxatidine

A02BA07 Ranitidine bismuth citrate

A02BA08 Lafutidine

A02BA51 Cimetidine, combinations

A02BA53 Famotidine, combinations

A02BB Prostaglandins

A02BB01 Misoprostol

A02BB02 Enprostil

A02BC Proton pump inhibitors

A02BC01 Omeprazole

A02BC02 Pantoprazole

A02BC03 Lansoprazole

A02BC04 Rabeprazole

A02BC05 Esomeprazole

A02BC06 Dexlansoprazole

A02BC07 Dexrabeprazole

A02BC53 Lansoprazole, combinations

A02BC54 Rabeprazole, combinations

A02BD Combinations for eradication of Helicobacter pylori

A02BD01 Omeprazole, amoxicillin and metronidazole

A02BD02 Lansoprazole, tetracycline and metronidazole

A02BD03 Lansoprazole, amoxicillin and metronidazole

A02BD04 Pantoprazole, amoxicillin and clarithromycin

A02BD05 Omeprazole, amoxicillin and clarithromycin

A02BD06 Esomeprazole, amoxicillin and clarithromycin

A02BD07 Lansoprazole, amoxicillin and clarithromycin

A02BD08 Bismuth subcitrate, tetracycline and metronidazole

A02BD09 Lansoprazole, clarithromycin and tinidazole

A02BD10 Lansoprazole, amoxicillin and levofloxacin

A02BD11 Pantoprazole, amoxicillin, clarithromycin and metronidazole

A02BX Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)

A02BX01 Carbenoxolone

A02BX02 Sucralfate

A02BX03 Pirenzepine

A02BX04 Methiosulfonium chloride

A02BX05 Bismuth subcitrate

A02BX06 Proglumide

A02BX07 Gefarnate

A02BX08 Sulglicotide

A02BX09 Acetoxolone

A02BX10 Zolimidine

A02BX11 Troxipide

A02BX12 Bismuth subnitrate

A02BX13 Alginic acid

A02BX51 Carbenoxolone, combinations excluding psycholeptics

A02BX71 Carbenoxolone, combinations with psycholeptics

A02BX77 Gefarnate, combinations with psycholeptics

A02X Other drugs for acid related disorders

Empty

References

↑ "ATC/DDD Index 2016: code A02". WHO Collaborating Centre for Drug Statistics Methodology.
↑ "ATCvet Index 2016: code QA02". WHO Collaborating Centre for Drug Statistics Methodology.

Drugs for acid related disorders: Antacids (A02A)

Magnesium (increases motility)	Magnesium carbonate Magnesium oxide Magnesium peroxide Magnesium hydroxide Magnesium silicate

Aluminium (decreases motility)	Algeldrate Aluminium phosphate Aluminium acetoacetate Aloglutamol Aluminium glycinate Carbaldrate

Calcium	Calcium carbonate Calcium silicate

Sodium	Sodium bicarbonate

Combinations and complexes of aluminium, calcium and magnesium	Almagate Almasilate Hydrotalcite Magaldrate

Drugs for peptic ulcer and GERD/GORD (A02B)

H₂ antagonists ("-tidine")	Cimetidine Famotidine Lafutidine Lavoltidine (loxtidine) Niperotidine Nizatidine Ranitidine Roxatidine

Prostaglandins (E)/analogues ("-prost-")	Misoprostol Enprostil

Proton-pump inhibitors ("-prazole")	Dexlansoprazole Esomeprazole Ilaprazole Lansoprazole Omeprazole Pantoprazole Picoprazole Rabeprazole Tenatoprazole Timoprazole

Potassium-competitive acid blockers ("-prazan")	Linaprazan Revaprazan Soraprazan Vonoprazan

Other	Acetoxolone Alginic acid Arbaclofen placarbil Carbenoxolone Cetraxate Gefarnate Lesogaberan Pirenzepine Proglumide Rebamipide Sucralfate Sulglicotide Telenzepine Teprenone Troxipide Zolimidine

Combinations	Bismuth subcitrate/metronidazole/tetracycline

See also: Helicobacter pylori* eradication protocols*

This article is issued from Wikipedia - version of the Monday, January 04, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.